ClassID:

95625

C07D513/18 - CPC Classification

Classification description:

Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or  -  in which the condensed system contains three hetero rings Bridged systems

Recent Application in this class:
#1
20260137703
2026-05-21

2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

#2
20260078133
2026-03-19

RAS INHIBITORS

#3
20260008784
2026-01-08

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL USE FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES

#4
20250197421
2025-06-19

MCL1 INHIBITORS

#5
20240374608
2024-11-14

USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION

#6
20240287099
2024-08-29

1,4-sulfur-bridged polycyclic compounds containing dihydrobenzofuran structure, its preparation method and application thereof

#7
20240279233
2024-08-22

MACROCYCLIC TAK1 INHIBITORS

#8
20240101571
2024-03-28

NLRP3 MODULATORS

#9
20240067660
2024-02-29

MACROCYCLIC SPIROCYCLE DERIVATIVES AS MCL-1 INHIBITORS

#10
20240059709
2024-02-22

Synthesis of structural analogs of largazole and associated compounds

#11
20230357269
2023-11-09

NEW MACROCYCLIC LRRK2 KINASE INHIBITORS

#12
20230348494
2023-11-02

MCL1 inhibitors

#13
20230322805
2023-10-12

NOVEL PYRIMIDODIAZEPINE DERIVATIVES OR USES THEREOF

#14
20230192692
2023-06-22

MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF

#15
20230183258
2023-06-15

NLRP3 MODULATORS

#16
20230131668
2023-04-27

HEAT SHOCK PROTEIN MODULATORS AND ANTI-HUNTINGTON DISEASE THERAPEUTIC AGENTS

#17
20230058950
2023-02-23

Urea compound having substituent

#18
20230057592
2023-02-23

USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION

#19
20220389031
2022-12-08

MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

#20
20220153741
2022-05-19

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12C

#21
20220071971
2022-03-10

MACROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASE

#22
20210292336
2021-09-23

NLRP3 modulators

#23
20210275542
2021-09-09

Heterocyclic compounds and their use in preventing or treating bacterial infections

#24
20210171543
2021-06-10

MCL1 inhibitors

#25
20210155637
2021-05-27

Fused pentacyclic imidazole derivatives

#26
20210115066
2021-04-22

Dithio ETP derivatives

#27
20210106590
2021-04-15

Use of H3K9me3 modulation for enhancing cognitive function

#28
20200277307
2020-09-03

Synthesis of ETP derivatives

#29
20200024278
2020-01-23

COMPOSITION COMPRISING ANTIBIOTIC COMPOUND AND AN HETEROCYCLIC COMPOUND AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS

#30
20190367535
2019-12-05

Fused pentacyclic imidazole derivatives

#31
20190225615
2019-07-25

Purine and 3-deazapurine analogues as choline kinase inhibitors

#32
20190211034
2019-07-11

Dithio ETP derivatives

#33
20190209577
2019-07-11

Use of H3K9me3 modulation for enhancing cognitive function

#34
20190175561
2019-06-13

Heterocyclic compounds and their use in preventing or treating bacterial infections

#35
20180243269
2018-08-30

Forazolines, compositions thereof and uses thereof

#36
20180228808
2018-08-16

Use of H3K9me3 modulation for enhancing cognitive function

#37
20180155367
2018-06-07

ETP derivatives

#38
20180118765
2018-05-03

Heterocyclic compounds and their use in preventing or treating bacterial infections

#39
20180057510
2018-03-01

Synthesis and utility of new capgroup largazole analogs

#40
20180044376
2018-02-15

Method for preparing largazole analogs and uses thereof

#41
20180044338
2018-02-15

SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS

#42
20170355697
2017-12-14

Substituted bridged urea analogs as sirtuin modulators

#43
20170305932
2017-10-26

Fused pentacyclic imidazole derivatives

#44
20170037058
2017-02-09

ETP derivatives

#45
20160083386
2016-03-24

Substituted bridged urea analogs as sirtuin modulators

#46
20160024113
2016-01-28

Macrocyclic salt-inducible kinase inhibitors

#47
20160002265
2016-01-07

Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseases

#48
20150291622
2015-10-15

ETP derivatives

#49
20150152108
2015-06-04

Substituted bridged urea analogs as sirtuin modulators

#50
20150051197
2015-02-19

Heterocyclic compound and use thereof

#51
20140364385
2014-12-11

Forazolines, compositions thereof and uses thereof

#52
20140303026
2014-10-09

Compounds for modulating integrin CD11B/CD18

#53
20140135339
2014-05-15

Macrocyclic derivatives for the treatment of diseases

#54
20140107101
2014-04-17

Macrocyclic indole derivatives useful as hepatitis C virus inhibitors

#55
20140093449
2014-04-03

Method for preparing largazole analogs and uses thereof

#56
20140088016
2014-03-27

Macrocyclic therapeutic agents and methods of treatment

#57
20140031400
2014-01-30

Macrocyclic compounds and methods of treatment

#58
20130296330
2013-11-07

MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS

#59
20130252961
2013-09-26

Macrocyclic derivatives for the treatment of diseases

#60
20130079297
2013-03-28

KINASE PROTEIN BINDING INHIBITORS

#61
20130045967
2013-02-21

Compounds for modulating integrin CD11b/CD18

#62
20130045925
2013-02-21

Compositions for ameliorating cell proliferative disorders and methods of making and using them

#63
20120264794
2012-10-18

Method for preparing largazole analogs and uses thereof

#64
20120211731
2012-08-23

Adduct compound, methods for purification and preparation of fused polycyclic aromatic compound, solution for formation of organic semiconductor film, and novel alpha-diketone compound

#65
20120172367
2012-07-05

Macrocyclic integrase inhibitors

#66
20120156295
2012-06-21

Antibiotic compounds

#67
20120095065
2012-04-19

Macrocyclic compounds and methods of treatment

#68
20120076755
2012-03-29

Hepatitis C virus inhibitors

#69
20120046281
2012-02-23

RIFALAZIL COMPOSITIONS AND THERAPEUTIC REGIMENS

#70
20110294801
2011-12-01

Macrocyclics pyrimidines as aurora kinase inhibitors

#71
20110218195
2011-09-08

METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS AND DISEASES ASSOCIATED THEREWITH

#72
20110123644
2011-05-26

MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT

#73
20110118323
2011-05-19

Macrocyclic compounds and methods of treatment

#74
20110105473
2011-05-05

Macrocyclic indole derivatives useful as hepatitis C virus inhibitors

#75
20110065664
2011-03-17

Kinase protein binding inhibitors

#76
20100273765
2010-10-28

Rifamycin analogs and uses thereof

#77
20100266507
2010-10-21

Luminescent compounds

#78
20100256180
2010-10-07

Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function

#79
20100081700
2010-04-01

Hepatitis C virus inhibitors

#80
20100076046
2010-03-25

Antiviral indoles

#81
20100056510
2010-03-04

Macrocyclic compound

#82
20100056503
2010-03-04

Compounds for modulating integrin CD11b/CD18

#83
20100029731
2010-02-04

Method for preparing largazole analogs and uses thereof

#84
20090149453
2009-06-11

METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS AND DISEASES ASSOCIATED THEREWITH

#85
20090088423
2009-04-02

METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS AND DISEASES ASSOCIATED THEREWITH

#86
20090048239
2009-02-19

Therapeutic compounds

#87
20080290034
2008-11-27

Bridged macrocyclic module compositions

#88
20080214522
2008-09-04

Antiviral indoles

#89
20050197333
2005-09-08

Rifamycin analogs and uses thereof

#90
20050154199
2005-07-14

Bridged macrocyclic module compositions

#91
20050043298
2005-02-24

Rifamycin analogs and uses thereof